Adiponectin is associated with vascular function independent of insulin sensitivity
JM Fernández-Real, A Castro, G Vazquez… - Diabetes …, 2004 - Am Diabetes Assoc
JM Fernández-Real, A Castro, G Vazquez, R Casamitjana, A López-Bermejo, G Peñarroja…
Diabetes care, 2004•Am Diabetes AssocOBJECTIVE—Adiponectin has been proposed to play important roles in the regulation of
energy homeostasis and insulin sensitivity. In experimental studies, adiponectin has also
been found to inhibit vascular smooth muscle cell proliferation. Decreased adiponectin
levels have been described in patients with coronary artery disease, and circulating
adiponectin predicts cardiovascular death in patients with renal failure. Because adiponectin
appears to influence both insulin sensitivity and vessel wall physiology, we examined insulin …
energy homeostasis and insulin sensitivity. In experimental studies, adiponectin has also
been found to inhibit vascular smooth muscle cell proliferation. Decreased adiponectin
levels have been described in patients with coronary artery disease, and circulating
adiponectin predicts cardiovascular death in patients with renal failure. Because adiponectin
appears to influence both insulin sensitivity and vessel wall physiology, we examined insulin …
OBJECTIVE—Adiponectin has been proposed to play important roles in the regulation of energy homeostasis and insulin sensitivity. In experimental studies, adiponectin has also been found to inhibit vascular smooth muscle cell proliferation. Decreased adiponectin levels have been described in patients with coronary artery disease, and circulating adiponectin predicts cardiovascular death in patients with renal failure. Because adiponectin appears to influence both insulin sensitivity and vessel wall physiology, we examined insulin sensitivity and vascular function in relation with circulating adiponectin.
RESEARCH DESIGN AND METHODS—We studied brachial artery vascular reactivity (high-resolution external ultrasound) and insulin sensitivity (minimal model) in 68 healthy subjects. Brachial artery vascular reactivity was also determined in 52 patients with altered glucose tolerance: 30 subjects with impaired fasting glucose (IFG) or glucose intolerance (GIT) and 22 patients with type 2 diabetes.
RESULTS—Circulating adiponectin concentration was significantly associated with insulin sensitivity (r = 0.29, P = 0.02) and with fasting serum triglycerides (r = −0.29, P = 0.02) in healthy subjects. In the latter, adiponectin levels were positively associated with arterial vasodilation in response to nitroglycerin (endothelium-independent vasodilation [EIVD], r = 0.41, P = 0.002) but not with flux-induced, endothelium-dependent vasodilation (EDVD) (r = 0.007, P = NS). In contrast, EIVD was not significantly associated with adiponectin in subjects with IFG, GIT, or type 2 diabetes (r ≤ 0.10, P = NS). In a multiple linear regression analysis to predict EIVD in healthy subjects, age (P = 0.012), sex (P = 0.042), and adiponectin concentration (P = 0.045), but not BMI, insulin sensitivity, or fasting triglycerides, contributed to 39% of EIVD variance.
CONCLUSIONS—Serum adiponectin concentration appears to be significantly associated with vascular function in apparently healthy humans. This association seems to be independent of its link with insulin sensitivity.
Am Diabetes Assoc
